November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website. “We are now ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

Alfredo Juarez Zeferino, known as Lelo, is a Mexican farmworker and co-founder of Familias Unidas por la Justicia, an ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...